Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mengya Chen, Xingxing Hu, Meng Wu, Jiajia Yang, Renfang Han, Yubo Ma, Xu Zhang, Yaping Yuan, Rui Liu, Mengmeng Wang, Guangming Jiang, Jixiang Deng, Shengqian Xu, Jianhua Xu, Zongwen Shuai & Faming Pan. (2019) Serum Levels of OPG, RANKL, and RANKL/OPG Ratio in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-analysis. Immunological Investigations 48:5, pages 490-504.
Read now
Read now
Articles from other publishers (50)
Weizhen Weng, Yanli Zhang, Lian Gui, Jingrong Chen, Weihang Zhu, Zhenguo Liang, Zhongming Wu, Yao Liang, Jiewen Xie, Qiujing Wei, Zetao Liao, Jieruo Gu, Yunfeng Pan & Yutong Jiang. (2023) PKM2 promotes proinflammatory macrophage activation in ankylosing spondylitis. Journal of Leukocyte Biology 114:6, pages 595-603.
Crossref
Crossref
Koen Venken, Matthias Jarlborg, Tine Decruy, Céline Mortier, Carolien Vlieghe, Elisabeth Gilis, Ann-Sophie De Craemer, Julie Coudenys, Isabelle Cambré, Devan Fleury, Alexander Klimowicz, Filip Van den Bosch, Anne Hoorens, Triana Lobaton, Sytze de Roock, Tim Sparwasser, Gerald Nabozny, Peggy Jacques & Dirk Elewaut. (2023) Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis. Annals of the Rheumatic Diseases 82:8, pages 1076-1090.
Crossref
Crossref
Chuyu Xiao, Jingyang Zhou & Bin Zhang. (2023) Differentially expressed protein‐coding genes in ankylosing spondylitis: Emerging insights into pathogenesis and therapeutic approaches. International Journal of Rheumatic Diseases 26:8, pages 1440-1452.
Crossref
Crossref
Yongchen Bie, Xiujun Zheng, Xiaojiong Chen, Xiangyun Liu, Liqin Wang, Yuanliang Sun & Jianqiang Kou. (2023) RNA sequencing and bioinformatics analysis of differentially expressed genes in the peripheral serum of ankylosing spondylitis patients. Journal of Orthopaedic Surgery and Research 18:1.
Crossref
Crossref
Arthur Kavanaugh, Xenofon Baraliakos, Sheng Gao, Warner Chen, Kristen Sweet, Soumya D. Chakravarty, Qingxuan Song, May Shawi & Proton Rahman. (2023) Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials. Advances in Therapy 40:5, pages 2439-2456.
Crossref
Crossref
Cunyi WANG, Ji'an HU & Jiejun SHI. (2023) Role of Interleukin-36 in inflammatory joint diseases. Journal of Zhejiang University (Medical Sciences) 52:2, pages 249-259.
Crossref
Crossref
Münevver Serdaroğlu Beyazal, Aliekber Tayfun, Gul Devrimsel, Murat Yıldırım & Medeni Arpa. (2022) Association of Serum Interleukin-17 and Interleukin-23 Levels with
Disease Activity, Function, Mobility, Enthesitis Index in Patients with
Ankylosing Spondylitis. Aktuelle Rheumatologie 48:02, pages 131-136.
Crossref
Crossref
Adhraa S. Jaber & Ali H. Ad'hiah. (2023) A novel signature of interleukins 36α, 37, 38, 39 and 40 in ankylosing spondylitis. Cytokine 162, pages 156117.
Crossref
Crossref
Mauro Fatica, Arianna D’Antonio, Lucia Novelli, Paola Triggianese, Paola Conigliaro, Elisabetta Greco, Alberto Bergamini, Carlo Perricone & Maria Sole Chimenti. (2022) How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management. Current Rheumatology Reports 25:1, pages 12-33.
Crossref
Crossref
Xuegang Li, Anqi Liang, Yujie Cui, Juan Liao, Xueling Fang & Shuping Zhong. (2022) Role of macrophage-associated chemokines in the assessment of initial axial spondyloarthritis. Clinical Rheumatology 41:11, pages 3383-3389.
Crossref
Crossref
Chenxing Zhou, Tuo Liang, Jie Jiang, Zide Zhang, Jiarui Chen, Tianyou Chen, Liyi Chen, Xuhua Sun, ShengSheng Huang, Jichong Zhu, Shaofeng Wu, Xinli Zhan & Chong Liu. (2022) Immune cell infiltration-related clinical diagnostic model for Ankylosing Spondylitis. Frontiers in Genetics 13.
Crossref
Crossref
Bin Liu, Zhenghua Ding, Junhui Xiong, Xing Heng, Huafu Wang & Weihua Chu. (2022) Gut Microbiota and Inflammatory Cytokine Changes in Patients with Ankylosing Spondylitis. BioMed Research International 2022, pages 1-6.
Crossref
Crossref
Simin Luo, Xiang Xiao, Wenting Luo, Xuan Zhang, Jian Zhang & Songqi Tang. (2022) Investigating the Molecular Mechanism of Qianghuo Shengshi Decoction in the Treatment of Ankylosing Spondylitis Based on Network Pharmacology and Molecular Docking Analysis. Processes 10:8, pages 1487.
Crossref
Crossref
Hsien-Tzung Liao, Chang-Youh Tsai, Chien-Chih Lai, Song-Chou Hsieh, Yi-Syuan Sun, Ko-Jen Li, Chieh-Yu Shen, Cheng-Han Wu, Cheng-Hsun Lu, Yu-Min Kuo, Tzu-Hao Li, Chung-Tei Chou & Chia-Li Yu. (2022) The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Narjes Soleimanifar & Alireza Rezaiemanesh. 2022. Ankylosing Spondylitis - Axial Spondyloarthritis. Ankylosing Spondylitis - Axial Spondyloarthritis
25
48
.
Dan Huang, Jian Liu, Lei Wan, Yanyan Fang, Yan Long, Ying Zhang & Bingxi Bao. (2021) Identification of lncRNAs associated with the pathogenesis of ankylosing spondylitis. BMC Musculoskeletal Disorders 22:1.
Crossref
Crossref
Vibeke Strand, Atul Deodhar, Rieke Alten, Emma Sullivan, Stuart Blackburn, Haijun Tian, Kunal K. Gandhi, Steffen M. Jugl & Philip G. Conaghan. (2021) Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors. JCR: Journal of Clinical Rheumatology 27:8, pages e446-e455.
Crossref
Crossref
Y. H. Lee & G. G. Song. (2020) Circulating interleukin-23 levels in ankylosing spondylitis and their correlation with disease activityWerte für zirkulierendes Interleukin-23 bei Spondylitis ankylosans und Korrelation mit der Krankheitsaktivität. Zeitschrift für Rheumatologie 80:7, pages 663-669.
Crossref
Crossref
Lifei Liu, Yu Yuan, Shihua Zhang, Jiake Xu & Jun Zou. (2021) Osteoimmunological insights into the pathogenesis of ankylosing spondylitis. Journal of Cellular Physiology 236:9, pages 6090-6100.
Crossref
Crossref
Hu Qin, Tao Wu, Jun Liu, Gang Wang, Lei Fan, Boyao Wang & Yajun Shen. (2021) MALT-1 inhibition attenuates the inflammatory response of ankylosing spondylitis by targeting NF-κB activation. Injury 52:6, pages 1287-1293.
Crossref
Crossref
Yang Zhang, Chao Ning, Huijie Zhou, Yingjie Yan, Fulai Liu & Yayun Huang. (2020) Interleukin-1β, interleukin-6, and interleukin-17A as indicators reflecting clinical response to celecoxib in ankylosing spondylitis patients. Irish Journal of Medical Science (1971 -) 190:2, pages 631-638.
Crossref
Crossref
Inderjeet Verma, Pawan Krishan & Ashit Syngle. (2021) Therapeutic potential of spironolactone in ankylosing spondylitis patients: Relation to disease activity and functional status. The Egyptian Rheumatologist 43:2, pages 173-178.
Crossref
Crossref
Sônia Maria A. Anti Loduca Lima & Michel Alexandre Yazbek. (2020) Exames complementares das entesopatias. Parte 1 – Biomarcadores. Revista Paulista de Reumatologia:2020 out-dez;19(4), pages 60-64.
Crossref
Crossref
Maria Sole Chimenti, Carlo Perricone, Paola Conigliaro, Paola Triggianese, Arianna D'Antonio, Erica de Martino, Giulia Lavinia Fonti, Francesco Caso, Luisa Costa & Roberto Perricone. (2020) Tackling the autoimmune side in Spondyloarthritis: A systematic review. Autoimmunity Reviews 19:10, pages 102648.
Crossref
Crossref
Matthew A. Brown, Zhixiu Li & Kim-Anh Lê Cao. (2020) Biomarker development for axial spondyloarthritis. Nature Reviews Rheumatology 16:8, pages 448-463.
Crossref
Crossref
Arthur Petitdemange, Julien Blaess, Jean Sibilia, Renaud Felten & Laurent Arnaud. (2020) Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis. Therapeutic Advances in Musculoskeletal Disease 12, pages 1759720X2096926.
Crossref
Crossref
Mariagrazia Lorenzin, Francesca Ometto, Augusta Ortolan, Mara Felicetti, Marta Favero, Andrea Doria & Roberta Ramonda. (2020) An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision. Therapeutic Advances in Musculoskeletal Disease 12, pages 1759720X2093427.
Crossref
Crossref
Daniel E. Furst & James S. Louie. (2019) Targeting inflammatory pathways in axial spondyloarthritis. Arthritis Research & Therapy 21:1.
Crossref
Crossref
Hulya DeveciAyla Caglıyan TurkZeliha Cansel OzmenKoksal Deveci. (2019) Serum Interleukin-23/17 Levels in Ankylosing Spondylitis Patients Treated with Nonsteroidal Anti-Inflammatory Drugs: A Prospective Cohort Study. Journal of Interferon & Cytokine Research 39:9, pages 572-576.
Crossref
Crossref
Xu Zhang, Yaping Yuan, Zhipeng Pan, Yubo Ma, Meng Wu, Jiajia Yang, Renfang Han, Mengya Chen, Xingxing Hu, Rui Liu, Napoleon Bellua Sam, Shengqian Xu & Faming Pan. (2019) Elevated circulating IL-17 level is associated with inflammatory arthritis and disease activity: A meta-analysis. Clinica Chimica Acta 496, pages 76-83.
Crossref
Crossref
Mariagrazia Lorenzin, Augusta Ortolan, Mara Felicetti, Marta Favero, Stefania Vio, Martina Zaninotto, Pamela Polito, Chiara Cosma, Vanna Scapin, Carmelo Lacognata & Roberta Ramonda. (2019) Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study). Frontiers in Medicine 6.
Crossref
Crossref
Seyed Shahabeddin Mortazavi-Jahromi, Sepideh Nazeri, Fahimeh Jafarnezhad-Ansariha, Mona Oraei & Abbas Mirshafiey. (2018) Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties. Immunologic Research 67:1, pages 108-115.
Crossref
Crossref
Wei Liu, Lili Huang, Cuiying Zhang & Zuozhong Liu. (2018) lncRNA MEG3 is downregulated in ankylosing spondylitis and associated with disease activity, hospitalization time and disease duration. Experimental and Therapeutic Medicine.
Crossref
Crossref
Nergiz Zorbozan, Süleyman Demir & Veli Çobankara. (2018) Evaluation of the relationship between TNFα, sTNFR1, sTNFR2, sIL2R, IL6, neopterin with disease activity in ankylosing spondylitis. Turkish Journal of Biochemistry 43:5, pages 487-494.
Crossref
Crossref
Yong YanTuan-Mao GuoChao Zhu. (2018) Effects of nonsteroidal anti-inflammatory drugs on serum proinflammatory cytokines in the treatment of ankylosing spondylitis. Biochemistry and Cell Biology 96:4, pages 450-456.
Crossref
Crossref
Alireza Rezaiemanesh, Mohsen Abdolmaleki, Kamal Abdolmohammadi, Hamideh Aghaei, Fatemeh Dadgar Pakdel, Yousef Fatahi, Narjes Soleimanifar, Mahdi Zavvar & Mohammad Hossein Nicknam. (2018) Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomedicine & Pharmacotherapy 100, pages 198-204.
Crossref
Crossref
Leticia Garcia-Montoya, Hanna Gul & Paul Emery. (2018) Recent advances in ankylosing spondylitis: understanding the disease and management. F1000Research 7, pages 1512.
Crossref
Crossref
Jie-En Pan, Fei-Long Xiong, Gang Chen, Zhong-Wei Zhang & You-Jia Xu. (2017) Aquaporin-1 expression as an indicator in evaluating the efficacy of meloxicam in the treatment of ankylosing spondylitis: A comparative study. Biomedicine & Pharmacotherapy 95, pages 1549-1555.
Crossref
Crossref
Dongyi He, Qi Zhu, Quan Zhou, Qing Qi, Hongmei Sun, Liza M. Zachariah, Grace Wang, John D. Reveille, Yongtao Guan & Xiaodong Zhou. (2017) Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study. Clinical Rheumatology 36:8, pages 1819-1826.
Crossref
Crossref
In?s P. Perp?tuo, Joana Caetano-Lopes, Elsa Vieira-Sousa, Raquel Campanilho-Marques, Cristina Ponte, Helena Canh?o, Mari Ainola & Jo?o E. Fonseca. (2017) Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors. Frontiers in Medicine 4.
Crossref
Crossref
Eun-Jin LeeBongkun ChoiEui-Seung HwangEun-Ju Chang. (2017) Interleukin-32 Gamma as a New Face in Inflammatory Bone Diseases. Journal of Rheumatic Diseases 24:1, pages 14.
Crossref
Crossref
Fernanda Manente Milanez, Carla G. S. Saad, Vilma T. Viana, J?lio C. B. Moraes, Gr?gory Vin?cius P?rico, Percival Degrava Sampaio-Barros, C?lio R. Goncalves & Elo?sa Bonf?. (2016) IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Abdellah El Maghraoui, Fran?ois Bertin Ebo?o, Siham Sadni, Abderrahim Majjad, Toufik Hamza & Aziza Mounach. (2016) Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?. BMC Musculoskeletal Disorders 17:1.
Crossref
Crossref
Sevgi Baspinar, Mehmet Kırnap, Osman Baspınar, Oguzhan Sıtkı Dizdar & Derya Kocer. (2016) Serum prolidase level in ankylosing spondylitis: low serum levels as a new potential gold standard biomarker for disease activity. Rheumatology International 36:11, pages 1609-1616.
Crossref
Crossref
Münevver Serdaroğlu Beyazal, Turan Erdoğan, Aysegül Kücükali Türkyılmaz, Gül Devrimsel, Medine Cumhur Cüre, Mehmet Beyazal & Ismail Sahin. (2016) Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis. Clinical Rheumatology 35:9, pages 2235-2241.
Crossref
Crossref
Jose Ram?n Vidal-Casti?eira, Antonio L?pez-V?zquez, Roberto Diaz-Pe?a, Paula Diaz-Bulnes, Pablo Martinez-Camblor, Eliecer Coto, Pablo Coto-Segura, Jacome Bruges-Armas, Jose Antonio Pinto, Francisco Jose Blanco, Alejandra S?nchez, Juan Mulero, Ruben Queiro & Carlos Lopez-Larrea. (2016) A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis. PLOS ONE 11:7, pages e0158905.
Crossref
Crossref
Jianing Wang, Qi Zhao, Gaoya Wang, Chunshu Yang, Yong Xu, Yujia Li & Pingting Yang. (2016) Circulating levels of Th1 and Th2 chemokines in patients with ankylosing spondylitis. Cytokine 81, pages 10-14.
Crossref
Crossref
Casper Steenholdt, Mehmet Coskun, Sine Buhl, Klaus Bendtzen, Mark A. Ainsworth, Jørn Brynskov & Ole H. Nielsen. (2016) Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease. Medicine 95:16, pages e3417.
Crossref
Crossref
Anita T. Shaw & Ellen M. Gravallese. (2016) Mediators of inflammation and bone remodeling in rheumatic disease. Seminars in Cell & Developmental Biology 49, pages 2-10.
Crossref
Crossref
John D. Reveille. (2015) Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clinical Rheumatology 34:6, pages 1009-1018.
Crossref
Crossref